I wonder how they plan to price this product should it get to market. They have stated the ingredients are cheap and plentiful I believe. Will they price it as a "last resort" treatment that we know will work if all else fails and is kept in reserve. Or will they price it in such a way that it becomes the primary treatment for target infections like sinusitis etc. Maybe they plan different marketing plans for simpler things like burns and sinusitis but maybe sepsis will be more of a last resort. Just speculating and dreaming of the day we have products in the market. The recent SAS treatment of recurring sinusitis seems like an incredible step forward.
Ann: Positive Sinusitis Patient Update - Special Access Scheme, page-80
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
0.010(3.33%) |
Mkt cap ! $89.39M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 31.5¢ | 31.0¢ | $1.865K | 6.015K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6135 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 18753 | 3 |
View Market Depth
| Last trade - 10.47am 27/06/2025 (20 minute delay) ? |
| RCE (ASX) Chart |